300109 Stock Overview Engages in the fine chemical and medical care businesses in China and internationally. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Add noteBoai NKY Medical Holdings Ltd. Competitors Price History & Performance
Summary of share price highs, lows and changes for Boai NKY Medical Holdings Historical stock prices Current Share Price CN¥16.81 52 Week High CN¥18.98 52 Week Low CN¥8.02 Beta 0.12 1 Month Change 15.06% 3 Month Change 62.57% 1 Year Change 44.33% 3 Year Change 12.67% 5 Year Change 55.36% Change since IPO -37.91%
Recent News & Updates
New minor risk - Shareholder dilution Oct 24
Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.30 in 3Q 2023) Oct 23
Investor sentiment deteriorates as stock falls 17% Oct 15
Boai NKY Medical Holdings Ltd. to Report Q3, 2024 Results on Oct 23, 2024 Sep 30
Investor sentiment improves as stock rises 22% Sep 28
Now 26% overvalued Sep 24 See more updates
New minor risk - Shareholder dilution Oct 24
Third quarter 2024 earnings released: EPS: CN¥0.21 (vs CN¥0.30 in 3Q 2023) Oct 23
Investor sentiment deteriorates as stock falls 17% Oct 15
Boai NKY Medical Holdings Ltd. to Report Q3, 2024 Results on Oct 23, 2024 Sep 30
Investor sentiment improves as stock rises 22% Sep 28
Now 26% overvalued Sep 24
Second quarter 2024 earnings released: EPS: CN¥0.20 (vs CN¥0.29 in 2Q 2023) Aug 30
Boai NKY Medical Holdings Ltd. to Report First Half, 2024 Results on Aug 30, 2024 Jun 29
Dividend increased to CN¥1.00 Jun 01
Boai NKY Medical Holdings Ltd. Announces Implementation of Final A Share Cash Dividend for 2023, Payable on 07 June 2024 Jun 01
Boai NKY Medical Holdings Ltd. Approves Cash Dividend for the Year 2023 May 26
Boai NKY Medical Holdings Ltd., Annual General Meeting, May 23, 2024 Apr 28
First quarter 2024 earnings released: EPS: CN¥0.38 (vs CN¥0.39 in 1Q 2023) Apr 27 Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for 2023
Now 23% overvalued after recent price rise Apr 03
Boai NKY Medical Holdings Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Mar 30
Full year 2023 earnings released: EPS: CN¥1.63 (vs CN¥0.88 in FY 2022) Feb 29
Boai NKY Medical Holdings Ltd. announced that it expects to receive CNY 623 million in funding Feb 22 Boai NKY Medical Holdings Ltd. announced that it expects to receive CNY 623 million in funding Feb 21
Investor sentiment deteriorates as stock falls 20% Feb 05
Boai NKY Medical Holdings Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024 Dec 30
Third quarter 2023 earnings released: EPS: CN¥0.45 (vs CN¥0.42 in 3Q 2022) Oct 25
Boai NKY Medical Holdings Ltd. to Report Q3, 2023 Results on Oct 25, 2023 Sep 30
Second quarter 2023 earnings released: EPS: CN¥0.44 (vs CN¥0.34 in 2Q 2022) Aug 30
Boai NKY Medical Holdings Ltd. Announces Final Dividend on A Shares for the Year 2022, Payable on May 30, 2023 May 25
Boai NKY Medical Holdings Ltd. Approves Cash Dividend for 2022 May 23
First quarter 2023 earnings released: EPS: CN¥0.39 (vs CN¥0.10 in 1Q 2022) Apr 28
Full year 2022 earnings released: EPS: CN¥0.96 (vs CN¥0.91 in FY 2021) Mar 06
Investor sentiment deteriorated over the past week Dec 23
High number of new directors Oct 31
Third quarter 2022 earnings released: EPS: CN¥0.42 (vs CN¥0.046 in 3Q 2021) Oct 25
Investor sentiment improved over the past week Sep 08
Investor sentiment improved over the past week Jul 20
Gryningskust Holding AB acquired additional 14.0 % minority stake in NeoDynamics AB (publ) (OM:NEOD). Jun 18
Boai NKY Medical Holdings Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on 30 May 2022 May 26
Boai NKY Medical Holdings Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on 30 May 2022 May 25
Boai Nky Medical Holdings Ltd. Approves Cash Dividend May 20
Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for the Year 2021 Apr 28
First quarter 2022 earnings released: EPS: CN¥0.10 (vs CN¥0.19 in 1Q 2021) Apr 27
High number of new and inexperienced directors Apr 27
Full year 2021 earnings: EPS in line with expectations, revenues disappoint Feb 28
Boai NKY Medical Holdings Ltd. (SZSE:300109) commences a Equity Buyback Plan under the authorization approved on December 21, 2021. Dec 27
Third quarter 2021 earnings released: EPS CN¥0.046 (vs CN¥0.08 in 3Q 2020) Oct 28
Second quarter 2021 earnings released: EPS CN¥0.067 (vs CN¥0.12 in 2Q 2020) Aug 29
Abcam plc (AIM:ABC) entered into a definitive agreement to acquire BioVision, Inc. from Boai NKY Medical Holdings Ltd. (SZSE:300109) for approximately $340 million. Aug 04
Investor sentiment improved over the past week Jul 23
Investor sentiment deteriorated over the past week Jul 09
Shanghai Haitong Securities Assets Management Co.,Ltd. completed the acquisition of 3% stake in Boai NKY Medical Holdings Ltd. (SZSE:300109) from Wang Donghu. Jun 05
Boai Nky Medical Holdings Ltd. Approves Final Cash Dividend for 2020 May 22
Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for 2020 Apr 30
First quarter 2021 earnings released: EPS CN¥0.19 (vs CN¥0.04 in 1Q 2020) Apr 30
Investor sentiment deteriorated over the past week Jan 29
New 90-day low: CN¥11.20 Jan 28
New 90-day low: CN¥11.89 Jan 11
Ningbo Tianlong Electronics Co., Ltd. (SHSE:603266) entered into a equity transfer agreement to acquire 4.1818% stake in Wuhan First Bioscience Inc. from Boai NKY Medical Holdings Ltd. (SZSE:300109) for CNY 14 million. Jan 08
New 90-day low: CN¥13.80 Dec 25
New 90-day low: CN¥15.06 Dec 09
New 90-day low: CN¥16.55 Nov 17
Third quarter earnings released Oct 30
Market bids up stock over the past week Oct 12
New 90-day high: CN¥19.40 Oct 12
New 90-day high: CN¥19.24 Sep 24
Fang Huasheng and Ren Dalong acquired 18.99% stake in Boai NKY Pharmaceuticals Ltd. (SZSE:300109). Sep 22
New 90-day high - CN¥18.63 Sep 08
Earnings released Aug 22
Boai NKY Medical Holdings Ltd. to Report First Half, 2020 Results on Aug 27, 2020 Aug 11
New 90-day high - CN¥18.55 Aug 10 Shareholder Returns 300109 CN Chemicals CN Market 7D 2.6% -2.3% -1.2% 1Y 44.3% 0.7% 11.8%
See full shareholder returns
Return vs Market: 300109 exceeded the CN Market which returned 11.8% over the past year.
Price Volatility Is 300109's price volatile compared to industry and market? 300109 volatility 300109 Average Weekly Movement 11.2% Chemicals Industry Average Movement 8.2% Market Average Movement 8.7% 10% most volatile stocks in CN Market 12.8% 10% least volatile stocks in CN Market 5.7%
Stable Share Price: 300109's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 300109's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company Boai NKY Medical Holdings Ltd. engages in the fine chemical and medical care businesses in China and internationally. The company offers polyvinylpyrrolidone (PVP) series products, and vinyl methyl ether and maleic acid products; anhydride copolymer (PVME/MA) series products; GBL, 2-pyrrolidone, NVP monomer, PVPK series (povidone), copovidone, and other VP/VA copolymer series products; and PVPP (cross-linked povidone), PVP-I, and related pharmaceutical intermediates.
Show more Boai NKY Medical Holdings Ltd. Fundamentals Summary How do Boai NKY Medical Holdings's earnings and revenue compare to its market cap? 300109 fundamental statistics Market cap CN¥8.15b Earnings (TTM ) CN¥399.35m Revenue (TTM ) CN¥1.49b
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) 300109 income statement (TTM ) Revenue CN¥1.49b Cost of Revenue CN¥737.63m Gross Profit CN¥750.25m Other Expenses CN¥350.90m Earnings CN¥399.35m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) 0.82 Gross Margin 50.42% Net Profit Margin 26.84% Debt/Equity Ratio 11.6%
How did 300109 perform over the long term?
See historical performance and comparison Dividends
4.0% Current Dividend Yield
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/23 16:33 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Boai NKY Medical Holdings Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Jun Liu Changjiang Securities Co. LTD. Zheng Zhou China Merchants Securities Co. Ltd. Zhenghua Zhang Founder Securities Co., Ltd.
Show 1 more analysts